Therefore modulation of both the NF-ĸB and STAT3 mediated transcriptions of IBD—Causing Th-17 cell factors is viewed as a novel probiotic therapeutic target in prevention and management of IBD [18,33]. This evidence concerns the gene STAT3 and inflammatory bowel disease.